Gene522
ATP5PF: ATP synthase peripheral stalk subunit F6
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ATP5PF: ATP synthase peripheral stalk subunit F6. Genes, record 522. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/522
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P18859 | ATP synthase peripheral stalk subunit F6, mitochondrial | 108 | 9 | Ensembl, GeneID, HGNC |
Source UniProt
Patents76
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 38120 | P18859 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38121 | P18859 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38122 | P18859 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38123 | P18859 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38124 | P18859 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3240 | P18859 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3240 | P18859 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 7089 | P18859 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 7090 | P18859 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 7091 | P18859 | Espacenet |
NIH grants771
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ATP5PF papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA042014 | Cancer Center Support Grant | 3 | 2025 |
| R35GM118141 | Mitochondrial Biogenesis in Health and Disease | 3 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 2 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 2 | 2025 |
| P30DK020593 | Vanderbilt Diabetes Research Center | 2 | 2025 |
| R01CA217987 | Metabolic barriers to T cell activation in clear cell renal cell carcinoma | 2 | 2025 |
| R01DK105550 | Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease | 2 | 2025 |
Source NIH's project files
Papers851
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The DDIT4L-TOM40-ATP5A pathway suppresses glioblastoma oncogenesis. | Genes Dis | 2027 | 42733534 | PubTator, text mining | PubMed |
| Stephania cepharantha Hayata (Baiyaozi) attenuates cirrhosis-associated intestinal barrier injury by restoring mitochondrial function and suppressing PI3K/AKT signaling. | J Ethnopharmacol | 2027 | 42586397 | PubTator, text mining | PubMed |
| Epithelial QKI Protects Against Emphysema by Maintaining Mitochondrial Integrity. | bioRxiv | 2026 | 42465480 | PubTator, text mining | PubMed |
| Generative design and validation of therapeutic peptides for glioblastoma based on a potential target ATP5A. | Brief Bioinform | 2026 | 42033056 | PubTator, text mining | PubMed |
| Stem cells enhance mitochondrial function in experimental Huntington's disease. | Stem Cells | 2026 | 41967079 | PubTator, text mining | PubMed |
| Short-Chain Fatty Acids and Palmitate Induce Distinct Metabolic and Phenotypic Signatures in Normal and Ischemic Skeletal Muscle Microvascular Endothelial Cells. | Cells | 2026 | 41892284 | PubTator, text mining | PubMed |
| Glycolytic reprogramming mediated by the ADAM12/IGF1 axis promotes ossification of the posterior longitudinal ligament. | Cell Death Discov | 2026 | 41881952 | PubTator, text mining | PubMed |
| Ambrisentan attenuates cisplatin-related mitochondrial dysfunction in the heart via regulation of p53 and NF-κB signaling. | Sci Rep | 2026 | 41876703 | PubTator, text mining | PubMed |
| Global molecular landscape of early MASLD progression in human obesity. | Elife | 2026 | 41870035 | PubTator, text mining | PubMed |
| COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function. | PLoS Genet | 2026 | 41824529 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/522
GET https://conductscience.org/api/genes/v1/522/patents?page=2